Dr. Rachel Grisham, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
10 reported clinical trials
13 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
Stage III
Stage II
2Fallopian Tube Cancer
Stage II
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Rachel Grisham, MD is currently running
Avutometinib + Defactinib + Letrozole
for Ovarian Cancer
The researchers are doing this study to find out whether the combination of avutometinib, defactinib, and letrozole is an effective treatment for people with low-grade serous ovarian cancer (LGSOC). The researchers will also look at the safety of this combination.
Recruiting1 award Phase 26 criteria
Second Look Laparoscopy
for Ovarian Cancer
The researchers are doing this study to look at the health outcomes of people with advanced ovarian cancer who have a second look laparoscopy (SLL) after they complete their first course of chemotherapy. The researchers will compare the health outcomes of people who have minimal residual disease (MRD-small amounts of cancer cells in the body after a person receives treatment) at the time of SLL with the health outcomes of people who do not have MRD at the time of SLL. The researchers are also doing this study to determine if SLL is safe and practical (feasible) in people with advanced ovarian cancer who have completed the first course of therapy for their disease.
Recruiting1 award Phase 2
More about Rachel Grisham, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Rachel Grisham, MD has experience with
- Defactinib
- Avutometinib
- Letrozole
- Avutometinib (VS-6766)
- Second Look Laparoscopy
- Peposertib
Breakdown of trials Rachel Grisham, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Ovarian Carcinoma
Fallopian Tube Serous Adenocarcinoma
Peritoneal Serous Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachel Grisham, MD specialize in?
Rachel Grisham, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Rachel Grisham, MD currently recruiting for clinical trials?
Yes, Rachel Grisham, MD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Rachel Grisham, MD has studied deeply?
Yes, Rachel Grisham, MD has studied treatments such as Defactinib, Avutometinib, Letrozole.
What is the best way to schedule an appointment with Rachel Grisham, MD?
Apply for one of the trials that Rachel Grisham, MD is conducting.
What is the office address of Rachel Grisham, MD?
The office of Rachel Grisham, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.